Princeton Longevity Medical Group

CLIA Laboratory Citation Details

3
Total Citations
8
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 31D1041308
Address 104 Carnegie Center Drive, Princeton, NJ, 08540
City Princeton
State NJ
Zip Code08540
Phone(888) 800-0752

Citation History (3 surveys)

Survey - September 25, 2024

Survey Type: Standard

Survey Event ID: SVQ811

Deficiency Tags: D5411 D5433 D5429 D5469

Summary:

Summary Statement of Deficiencies D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on surveyor review of analyzer Quality Control Records (QC), review of the Manufacturer QC Directions For Use (DFU) and interview with the Techincal Consultant (TC), the laboratory failed to follow the DFU for QC for Hematology testing performed on the Sysmex XN-430 from 7/13/21 to 9/25/24. The findings include: 1. The directions for use stated "XN-L Check is stored at 2-8C before and after opening. The period of use is 12 weeks per lot, with an open vial stability of 15 days if stored at 2 - 8 C. The volume is 3.0 mL per vial." 2. The TC stated "QC is used over 15 working days not calendar days" 3. The TC confirmed on 9/25/24 at 11:40 am, the laboratory failed to follow the DFU. D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on surveyor review of the Maintenance Records (MR) for the Tosoh AIA 360 analyzer, User Manual and interview with the Technical Consultant (TC) the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- laboratory failed to perform and document monthly maintenance as specified by the manufacturer for the Tosoh AIA 360 analyzer used for Endocrinology tests from March 1, 2023 to August 31, 2024. The finding includes: 1. There was no documented evidence for monthly maintenance performed in the months of March 2023, May 2023, September 2023, December 2023, Februrary 2024 and August 2024. 2. The TC confirmed on 9/25/24 at 1:15 pm there was no documented evidence for monthly maintenance performed for the Tosoh AIA 360 in the above mentioned months. D5433 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(b)(1) For equipment, instruments, or test systems developed in-house, commercially available and modified by the laboratory, or maintenance and function check protocols are not provided by the manufacturer, the laboratory must establish a maintenance protocol that ensures equipment, instrument, and test system performance that is necessary for accurate and reliable test results and test result reporting. The laboratory must perform and document the maintenance activities specified in paragraph (b)(1)(i) of this section. This STANDARD is not met as evidenced by: Based on surveyor review of the Procedure Manual (PM) and interview with the Technical Consultant (TC), the laboratory failed to establish a maintenance protocol for the Labomed CxL microscope used for Urine Microscopy tests from 7/13/21 to 9 /25/24. The findings include: 1. The PM did not have a maintenance protocol for the Labomed CxL microscope. 2. The TC confirmed on 9/25/24 at 11:00 am the laboratory did not have a maintenance protocol for the Labomed CxL microscope. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on surveyor review of Quality Control Verification (QCV) records and interview with the Technical Consultant (TC) , the laboratory failed to verify QC material before use for Alfa Wassweman Ace Alera from 7/3/21 to 9/25/24. The findings include. 1) There was no documented evidenced that the QCV was performed on the current lot of Alfa Wassermsan Controls. 2) The TC confirmed 9/25 /24 at 11:15 am that QC material was not verified before putting in use. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 13, 2021

Survey Type: Standard

Survey Event ID: TB6R11

Deficiency Tags: D5417 D5415 D6029

Summary:

Summary Statement of Deficiencies D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on surveyor observation of the Quality Control (QC) vials and interview with the Technical Consultant (TC), the laboratory failed to put an appropriate expiration date on the ELITechGroup ISE QC reagents in use on the Selectra Pro S analyzer on the date of the survey. The findings include: 1. The Manufacturers Package Insert (MPI) stated "After reconstitution: Stability of component: between 2-8 C for 7 days" 2. The laboratory failed to record expiration dates on the ELITechGroup ISE QC vials. 3. The TC confirmed on 7/13/21 at 11:00 am the laboratory failed to put appropriate expiration dates on the QC vials. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on surveyor review of the Quality Control (QC) Records and interview with the Technical Consultant (TC), the laboratory used expired ELITechGroup ISE QC Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- material for electrolyte testing from 7/7/21 to the date of survey. The findings include: 1. QC material expiration date changes once opened. 2. The laboratory was unaware that ELITechGroup ISE QC material expired 7 days after opening. 3. QC material in use was opened 6/24/21 and expired 7/1/21. 4. Approximately 32 patients were run and reported after 7/1/21. 5. The TC confirmed on 7/13/21 at 12:30 pm that the laboratory used expired QC material. D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on review of the Personnel Files (PF) and interview with Technical Consultant (TC), the Laboratory Director (LD) failed to have foreign education evaluated for one out of twoTesting Personnel (TP) performing nonwaived tests from June 2021 to the date of the survey. The finding includes: 1. The laboratory did not have a foreign education evaluation for one out of two TP. 2. The TC confirmed 7/13/21 at 10:30 am that the LD did not have foreign education evaluated. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 27, 2018

Survey Type: Standard

Survey Event ID: NDLY11

Deficiency Tags: D5469

Summary:

Summary Statement of Deficiencies D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on surveyor review of the Procedure Manual (PM), review of Quality Control (QC) data and interview with the Laboratory Consultant (LC), the laboratory failed to verify assayed QC material was within the acceptable range before it was put into use for Chemistry tests from May 2018 to the date of survey. The finding includes: 1. Review of the QC records revealed the controls listed below were not verified before use: a. Mas Liquimmune Control Lot # LIA20042 currently in use. c. Point Scientific Control Level 1 Lot # 807301 and Level II Lot # 807302 currently in use. d. ELITechGroup ISE control level 1 lot # 17-1250 and level II lot # 17-1355 currently in use. 2. The LC confirmed on 11/27/16 at 11:40 AM that the QC lots listed above were not verified. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access